In conclusion, we have used NGS-based liquid biopsy to detect alterations in several genes, including TP53, AR, ATM, MYC, and SPOP in PCa patients, which may be utilized for monitoring tumorigenesis. The gene discussed is TP53; the disease is posterior cortical atrophy.